Sort
64,565 grants matching “drug discovery”
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)
$4,278,987Thomas T Perls · Boston University Medical Campus · U19 · FY2021 · AG
Arming the Immune System Against Pathogens
$4,276,251Harvard University (Sch Of Public Hlth) · P01 · FY2004 · AI
Clinical and Translational Science Award
$4,274,173Marla J Keller · Albert Einstein College Of Medicine · UL1 · FY2021 · TR
Clinical and Translational Science Award
$4,274,173Marla J Keller · Albert Einstein College Of Medicine · UL1 · FY2022 · TR
Clinical and Translational Science Award
$4,274,173Harry Shamoon · Albert Einstein College Of Medicine · UL1 · FY2020 · TR
Clinical and Translational Science Award
$4,274,173Harry Shamoon · Albert Einstein College Of Medicine · UL1 · FY2019 · TR
EMORY CHEMISTRY-BIOLOGY CENTER IN THE MLSCN(RMI)
$4,272,029Raymond J Dingledine · Emory University · U54 · FY2007 · HG
Cincinnati Center for Clinical and Translational Sciences and Training
$4,270,383James E. Heubi · University Of Cincinnati · UL1 · FY2010 · RR
DCTD Synthetic Chemistry
$4,252,053David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
COG NCTN Network Group Operations Center
$4,245,531Richard Aplenc · Children'S Hosp Of Philadelphia · U10 · FY2020 · CA
Region VI Center for Biodefence and Emerging Infections
$4,242,615University Of Texas Medical Br Galveston · U54 · FY2003 · AI
Development of ALG-097431 as a broad-spectrum 3CL pro inhibitor
$4,228,031Julian A Symons · Hackensack University Medical Center · U19 · FY2022 · AI
Greater Southern California Node of the Clinical Trials Network
$4,227,936Yih-Ing Hser · University Of California Los Angeles · UG1 · FY2020 · DA
CSHL CANCER CENTER SUPPORT GRANT
$4,224,416Bruce W Stillman · Cold Spring Harbor Laboratory · P30 · FY2014 · CA
ADME/FORMULATION Core
$4,224,287Sean B. Joseph · Scripps Research Institute, The · U19 · FY2022 · AI
Understanding the mechanism of SPl1 dependent Alzheimer disease risk
$4,223,847Alison M Goate · Icahn School Of Medicine At Mount Sinai · RF1 · FY2016 · AG
Stanford Cancer Institute
$4,223,653Steven E Artandi · Stanford University · P30 · FY2023 · CA
Stanford Cancer Institute
$4,223,653Steven E Artandi · Stanford University · P30 · FY2024 · CA
Stanford Cancer Institute
$4,223,653Steven E Artandi · Stanford University · P30 · FY2022 · CA
Selective modulation of GPCR signal transduction with biased ligands
$4,214,058Michael William Lark · Trevena, Inc. · RC2 · FY2009 · MH
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$4,212,644Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR
Rationally designed targeted immunogens to elicit HIV Envelope V2-apex broadly neutralizing antibodies
$4,211,839Raiees Ahmad Andrabi · University Of Pennsylvania · U19 · FY2025 · AI
Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis
$4,211,117Bin Zhang · Icahn School Of Medicine At Mount Sinai · RF1 · FY2016 · AG
Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect
$4,198,428Carlos Zarate · National Institute Of Mental Health · ZIA · FY2016 · MH
Kentucky Center for Clinical and Translational Science
$4,198,128Philip A Kern · University Of Kentucky · UL1 · FY2019 · TR